Harrow Announces Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Harrow Health (HROW) Tops Q2 EPS by 2c
August 9, 2023 4:05 PM EDTHarrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $30.34 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
... MoreHarrow Health (HROW) Tops Q2 EPS by 2c
August 9, 2023 4:05 PM EDTHarrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.02), $0.02 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $33.5 million versus the consensus estimate of $30.34 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
... More